LB54640 Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity

Conditions:   Obesity Due to Melanocortin 4 Receptor Deficiency;   Genetic Obesity;   Obesity Intervention:   Drug: LB54640 Sponsor:   LG Chem Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials